GPs' implicit prioritization through clinical choices – evidence from three national health services
We present results from an extensive discrete choice experiment, which was conducted in three countries (Norway, Scotland, and England) with the aim of disclosing stated prescription behaviour in different decision making contexts and across different cost containment cultures. We show that GPs in a...
Gespeichert in:
Veröffentlicht in: | Journal of health economics 2016-09, Vol.49, p.169-183 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 183 |
---|---|
container_issue | |
container_start_page | 169 |
container_title | Journal of health economics |
container_volume | 49 |
creator | Riise, Julie Hole, Arne Risa Gyrd-Hansen, Dorte Skåtun, Diane |
description | We present results from an extensive discrete choice experiment, which was conducted in three countries (Norway, Scotland, and England) with the aim of disclosing stated prescription behaviour in different decision making contexts and across different cost containment cultures. We show that GPs in all countries respond to information about societal costs, benefits and effectiveness, and that they make trade-offs between them. The UK GPs have higher willingness to accept costs when they can prescribe medicines that are cheaper or more preferred by the patient, while Norwegian GPs tend to have higher willingness to accept costs for attributes regarding effectiveness or the doctors' experience. In general, there is a substantial amount of heterogeneity also within each country. We discuss the results from the DCE in the light of the GPs' two conflicting agency roles and what we know about the incentive structures and cultures in the different countries. |
doi_str_mv | 10.1016/j.jhealeco.2016.07.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1827889412</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0167629616300534</els_id><sourcerecordid>1827889412</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-b3eceac47db4eb11a79eac69efb8960566574418b94cb68e1bb241c5c85e452f3</originalsourceid><addsrcrecordid>eNqNkcFu1DAURS0EokPhFypLLGCT4Jdx7GQHqqAgVYIFrK345YU4SuLBTkYqK_6BP-RLcDotCzbgjfXkc6_texm7AJGDAPVqyIeempHQ50Wac6FzIeAB20Gl6wyUVA_ZLh3oTBW1OmNPYhxEWuW-fszOCi21EkLvWHf1Kb7gbjqMDt3CD8H54Bb3vVmcn_nSB79-7TmObnbYjBx775Ai__XjJ6eja2lG4l3w04YS8flWl8DtcUvPI4XjJnjKHnXNGOnZ3X7Ovrx7-_nyfXb98erD5ZvrDEsJS2b3hNSg1K2VZAEaXadR1dTZqlaiVKrUUkJla4lWVQTWFhKwxKokWRbd_py9PPkegv-2UlzM5CLSODYz-TUaqApdVbWE4n_QAkBLpRL6_C908GtI37ylymQotEyUOlEYfIyBOpPSnJpwY0CYrTQzmPvSzFaaEdqk0pLw4s5-tRO1f2T3LSXg9QmgFN3RUTAR3RZ96wLhYlrv_nXHbw26rQY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1825889074</pqid></control><display><type>article</type><title>GPs' implicit prioritization through clinical choices – evidence from three national health services</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><creator>Riise, Julie ; Hole, Arne Risa ; Gyrd-Hansen, Dorte ; Skåtun, Diane</creator><creatorcontrib>Riise, Julie ; Hole, Arne Risa ; Gyrd-Hansen, Dorte ; Skåtun, Diane</creatorcontrib><description>We present results from an extensive discrete choice experiment, which was conducted in three countries (Norway, Scotland, and England) with the aim of disclosing stated prescription behaviour in different decision making contexts and across different cost containment cultures. We show that GPs in all countries respond to information about societal costs, benefits and effectiveness, and that they make trade-offs between them. The UK GPs have higher willingness to accept costs when they can prescribe medicines that are cheaper or more preferred by the patient, while Norwegian GPs tend to have higher willingness to accept costs for attributes regarding effectiveness or the doctors' experience. In general, there is a substantial amount of heterogeneity also within each country. We discuss the results from the DCE in the light of the GPs' two conflicting agency roles and what we know about the incentive structures and cultures in the different countries.</description><identifier>ISSN: 0167-6296</identifier><identifier>EISSN: 1879-1646</identifier><identifier>DOI: 10.1016/j.jhealeco.2016.07.001</identifier><identifier>PMID: 27476007</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Benefit cost analysis ; Choice Behavior ; Containment ; Cost containment ; Cost control ; Costs ; Cultural differences ; Culture ; Decision making ; Discrete choice ; Discrete choice experiments ; Drugs ; England ; Family physicians ; GPs ; Health administration ; Health care expenditures ; Health services ; Heterogeneity ; Humans ; Medical personnel ; National Health Programs ; Norway ; Physicians ; Practice Patterns, Physicians ; Prescription behaviour ; Prescription Drugs ; Prioritization ; Scotland ; Studies</subject><ispartof>Journal of health economics, 2016-09, Vol.49, p.169-183</ispartof><rights>2016 Elsevier B.V.</rights><rights>Copyright © 2016 Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. Sep 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-b3eceac47db4eb11a79eac69efb8960566574418b94cb68e1bb241c5c85e452f3</citedby><cites>FETCH-LOGICAL-c541t-b3eceac47db4eb11a79eac69efb8960566574418b94cb68e1bb241c5c85e452f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jhealeco.2016.07.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,30999,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27476007$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Riise, Julie</creatorcontrib><creatorcontrib>Hole, Arne Risa</creatorcontrib><creatorcontrib>Gyrd-Hansen, Dorte</creatorcontrib><creatorcontrib>Skåtun, Diane</creatorcontrib><title>GPs' implicit prioritization through clinical choices – evidence from three national health services</title><title>Journal of health economics</title><addtitle>J Health Econ</addtitle><description>We present results from an extensive discrete choice experiment, which was conducted in three countries (Norway, Scotland, and England) with the aim of disclosing stated prescription behaviour in different decision making contexts and across different cost containment cultures. We show that GPs in all countries respond to information about societal costs, benefits and effectiveness, and that they make trade-offs between them. The UK GPs have higher willingness to accept costs when they can prescribe medicines that are cheaper or more preferred by the patient, while Norwegian GPs tend to have higher willingness to accept costs for attributes regarding effectiveness or the doctors' experience. In general, there is a substantial amount of heterogeneity also within each country. We discuss the results from the DCE in the light of the GPs' two conflicting agency roles and what we know about the incentive structures and cultures in the different countries.</description><subject>Benefit cost analysis</subject><subject>Choice Behavior</subject><subject>Containment</subject><subject>Cost containment</subject><subject>Cost control</subject><subject>Costs</subject><subject>Cultural differences</subject><subject>Culture</subject><subject>Decision making</subject><subject>Discrete choice</subject><subject>Discrete choice experiments</subject><subject>Drugs</subject><subject>England</subject><subject>Family physicians</subject><subject>GPs</subject><subject>Health administration</subject><subject>Health care expenditures</subject><subject>Health services</subject><subject>Heterogeneity</subject><subject>Humans</subject><subject>Medical personnel</subject><subject>National Health Programs</subject><subject>Norway</subject><subject>Physicians</subject><subject>Practice Patterns, Physicians</subject><subject>Prescription behaviour</subject><subject>Prescription Drugs</subject><subject>Prioritization</subject><subject>Scotland</subject><subject>Studies</subject><issn>0167-6296</issn><issn>1879-1646</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNqNkcFu1DAURS0EokPhFypLLGCT4Jdx7GQHqqAgVYIFrK345YU4SuLBTkYqK_6BP-RLcDotCzbgjfXkc6_texm7AJGDAPVqyIeempHQ50Wac6FzIeAB20Gl6wyUVA_ZLh3oTBW1OmNPYhxEWuW-fszOCi21EkLvWHf1Kb7gbjqMDt3CD8H54Bb3vVmcn_nSB79-7TmObnbYjBx775Ai__XjJ6eja2lG4l3w04YS8flWl8DtcUvPI4XjJnjKHnXNGOnZ3X7Ovrx7-_nyfXb98erD5ZvrDEsJS2b3hNSg1K2VZAEaXadR1dTZqlaiVKrUUkJla4lWVQTWFhKwxKokWRbd_py9PPkegv-2UlzM5CLSODYz-TUaqApdVbWE4n_QAkBLpRL6_C908GtI37ylymQotEyUOlEYfIyBOpPSnJpwY0CYrTQzmPvSzFaaEdqk0pLw4s5-tRO1f2T3LSXg9QmgFN3RUTAR3RZ96wLhYlrv_nXHbw26rQY</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Riise, Julie</creator><creator>Hole, Arne Risa</creator><creator>Gyrd-Hansen, Dorte</creator><creator>Skåtun, Diane</creator><general>Elsevier B.V</general><general>Elsevier Sequoia S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7T2</scope><scope>8BJ</scope><scope>C1K</scope><scope>FQK</scope><scope>JBE</scope><scope>K9.</scope><scope>7X8</scope><scope>7U2</scope></search><sort><creationdate>20160901</creationdate><title>GPs' implicit prioritization through clinical choices – evidence from three national health services</title><author>Riise, Julie ; Hole, Arne Risa ; Gyrd-Hansen, Dorte ; Skåtun, Diane</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-b3eceac47db4eb11a79eac69efb8960566574418b94cb68e1bb241c5c85e452f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Benefit cost analysis</topic><topic>Choice Behavior</topic><topic>Containment</topic><topic>Cost containment</topic><topic>Cost control</topic><topic>Costs</topic><topic>Cultural differences</topic><topic>Culture</topic><topic>Decision making</topic><topic>Discrete choice</topic><topic>Discrete choice experiments</topic><topic>Drugs</topic><topic>England</topic><topic>Family physicians</topic><topic>GPs</topic><topic>Health administration</topic><topic>Health care expenditures</topic><topic>Health services</topic><topic>Heterogeneity</topic><topic>Humans</topic><topic>Medical personnel</topic><topic>National Health Programs</topic><topic>Norway</topic><topic>Physicians</topic><topic>Practice Patterns, Physicians</topic><topic>Prescription behaviour</topic><topic>Prescription Drugs</topic><topic>Prioritization</topic><topic>Scotland</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Riise, Julie</creatorcontrib><creatorcontrib>Hole, Arne Risa</creatorcontrib><creatorcontrib>Gyrd-Hansen, Dorte</creatorcontrib><creatorcontrib>Skåtun, Diane</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>International Bibliography of the Social Sciences</collection><collection>International Bibliography of the Social Sciences</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Safety Science and Risk</collection><jtitle>Journal of health economics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Riise, Julie</au><au>Hole, Arne Risa</au><au>Gyrd-Hansen, Dorte</au><au>Skåtun, Diane</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GPs' implicit prioritization through clinical choices – evidence from three national health services</atitle><jtitle>Journal of health economics</jtitle><addtitle>J Health Econ</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>49</volume><spage>169</spage><epage>183</epage><pages>169-183</pages><issn>0167-6296</issn><eissn>1879-1646</eissn><abstract>We present results from an extensive discrete choice experiment, which was conducted in three countries (Norway, Scotland, and England) with the aim of disclosing stated prescription behaviour in different decision making contexts and across different cost containment cultures. We show that GPs in all countries respond to information about societal costs, benefits and effectiveness, and that they make trade-offs between them. The UK GPs have higher willingness to accept costs when they can prescribe medicines that are cheaper or more preferred by the patient, while Norwegian GPs tend to have higher willingness to accept costs for attributes regarding effectiveness or the doctors' experience. In general, there is a substantial amount of heterogeneity also within each country. We discuss the results from the DCE in the light of the GPs' two conflicting agency roles and what we know about the incentive structures and cultures in the different countries.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>27476007</pmid><doi>10.1016/j.jhealeco.2016.07.001</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0167-6296 |
ispartof | Journal of health economics, 2016-09, Vol.49, p.169-183 |
issn | 0167-6296 1879-1646 |
language | eng |
recordid | cdi_proquest_miscellaneous_1827889412 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete; Applied Social Sciences Index & Abstracts (ASSIA) |
subjects | Benefit cost analysis Choice Behavior Containment Cost containment Cost control Costs Cultural differences Culture Decision making Discrete choice Discrete choice experiments Drugs England Family physicians GPs Health administration Health care expenditures Health services Heterogeneity Humans Medical personnel National Health Programs Norway Physicians Practice Patterns, Physicians Prescription behaviour Prescription Drugs Prioritization Scotland Studies |
title | GPs' implicit prioritization through clinical choices – evidence from three national health services |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T10%3A59%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GPs'%20implicit%20prioritization%20through%20clinical%20choices%20%E2%80%93%20evidence%20from%20three%20national%20health%20services&rft.jtitle=Journal%20of%20health%20economics&rft.au=Riise,%20Julie&rft.date=2016-09-01&rft.volume=49&rft.spage=169&rft.epage=183&rft.pages=169-183&rft.issn=0167-6296&rft.eissn=1879-1646&rft_id=info:doi/10.1016/j.jhealeco.2016.07.001&rft_dat=%3Cproquest_cross%3E1827889412%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1825889074&rft_id=info:pmid/27476007&rft_els_id=S0167629616300534&rfr_iscdi=true |